Yank are you saying that our results bettered Humira's results even though MESO trial tested patients that failed 1,2 or more than 3 drug treatments?
Are you saying our trial results (although small in number) were comparable or better than Abbvies results.... while showing far less side effects?
Obviously this is ground breaking on so many levels.
Silvu did not want to rock the boat and go for first line approval. Smart
This trial will allow the drug to be used after standard of care.... for now. He is playing nice for a deal/partnership
Fantastic results that have shown the longevity of these cells.
Imagine if they could give 2 or 3 doses when it is warranted
- Forums
- ASX - By Stock
- MSB
- Two GREAT takeaways
Two GREAT takeaways, page-5
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
95.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.081B |
Open | High | Low | Value | Volume |
95.0¢ | 95.8¢ | 93.5¢ | $1.072M | 1.132M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 69416 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 47911 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 67388 | 0.945 |
29 | 184337 | 0.940 |
17 | 120019 | 0.935 |
20 | 240158 | 0.930 |
7 | 37950 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 39336 | 27 |
0.955 | 158763 | 18 |
0.960 | 75647 | 12 |
0.965 | 76779 | 7 |
0.970 | 48133 | 4 |
Last trade - 13.38pm 28/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
SPONSORED BY The Market Online